Reproductive process automation
The company’s technologies help standardize fertility treatments by simplifying techniques and optimizing resources.
Source: LinkedIn company description · Retrieved October 13, 2026
Overture Life is a clinical-stage biotechnology company focused on automating assisted reproductive processes.
The company aims to improve IVF pregnancy outcomes through process automation and non-invasive embryo selection. Overture is backed by Khosla Ventures, Felicis Ventures, Octopus Ventures and GV, and has offices in the U.S. and Spain.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company’s technologies help standardize fertility treatments by simplifying techniques and optimizing resources.
Source: LinkedIn company description · Retrieved October 13, 2026
The company pursues non-invasive embryo selection as part of its approach to improving IVF pregnancy outcomes.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 29, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 29, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.